Business Wire

Wisk Aero Acquires Leading Software Firm Verocel

Share

Wisk Aero, a leading Advanced Air Mobility (AAM) company, announced today it has acquired Verocel Inc., a software verification and validation (V&V) company. Verocel’s unique expertise in supporting the certification of high-integrity aerospace software and the qualification of V&V tools will play a key role in Wisk’s ongoing effort to certify its Generation 6 autonomous, electric air taxi.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240625141739/en/

Wisk Aero Acquires Verocel (Graphic: Business Wire)

For the past 25 years, the Verocel team has been leading the V&V of high-integrity software products within the aerospace industry. The team has deep expertise in DO-178C and are members of industry standards committees for high-integrity software including RTCA/Special Committee, EUROCAE Working Group, and the FAA's Overarching Properties Working Group. Additionally, the qualified Verocel toolset – VeroTrace – provides a baseline for software certification requirements definition, tracking, and FAA submittals. This specialty expertise creates an enduring capability at Wisk that supports both the certification of the Generation 6 aircraft as well as future software developments at The Boeing Company.

“High-integrity software development is critical for our mission to certify an autonomous, electric aircraft with V&V being a significant portion of the total software certification effort,” said Brian Yutko, Wisk CEO. “Verocel’s specialized and talented team will bring with them deep experience and rigor, helping to accelerate our autonomous certification project that is already well underway. We are thrilled to have this talented team join Wisk!”

Verocel was founded in 1999 and has a proven history with over 160 projects for 25+ customers including previous work with The Boeing Company. In addition to software development and V&V services, Verocel also develops and produces the safety computers for the Wide Area Augmentation System (WAAS), an air navigation system that enhances GPS accuracy and integrity to enable aircraft to safely navigate all over the world today. Over 50 highly specialized software engineers, based in Westford Massachusetts and Poznan, Poland, join Wisk through this acquisition.

“Wisk is a perfect alignment for Verocel, both in the long and short term,” said Jim Chelini, President of Verocel. “Not only is this a chance to directly apply our expertise to the certification of a groundbreaking technology, but this is also an incredible opportunity for Verocel talent to excel within Wisk and the broader Boeing ecosystem long term.”

Verocel will continue to deliver against customer commitments in addition to ramping up on the Wisk Generation 6 certification program.

About Wisk

Wisk is an Advanced Air Mobility (AAM) company dedicated to delivering safe, everyday flight for everyone. Wisk’s self-flying, eVTOL (electric vertical takeoff and landing) air taxi will make it possible for passengers to skip the traffic and get to their destination faster. Wisk is a fully-owned Boeing subsidiary and is headquartered in the San Francisco Bay Area, with locations around the world. With over a decade of experience and over 1700+ test flights, Wisk is shaping the future of daily commutes and urban travel, safely and sustainably. Learn more about Wisk here.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240625141739/en/

Contacts

Madeleine Finnegan
Media@wisk.aero
wisk.aero/media -
https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwisk.aero%2Fmed
ia&esheet=54086590&newsitemid=20240625141739&lan=en-US&anchor=wisk.aero%2Fmedia&
index=2&md5=d365f4ffa425cc4246038bc7feca0a48

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kweichow Moutai’s Brand Culture Activities in Greece Foster Sino-Greek Cultural Cooperation21.12.2024 19:41:00 CET | Press Release

On December 9th, the exhibition “Longevity in the Tao of Chrysanthemum: The Artistic World of Qi Baishi,” supported by Kweichow Moutai Group, opened at the Athens University History Museum. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241221429801/en/ Gao Shan(R3), and Petros Tatoulis(R2), took a group photo with other guests at the opening ceremony of the exhibition. (Photo: Business Wire) Featuring the works of Qi Baishi, a renowned Chinese painter, the exhibition highlights the unique charm of traditional Chinese culture for Western audiences, while advancing cultural exchange and mutual understanding between China and Greece. Gao Shan, Chairman of the Labor Union at Kweichow Moutai Distillery (Group) Co., Ltd., remarked on the significance of the event, saying, “Qi Baishi employed distinctive Eastern painting techniques to convey the Chinese perspective of the world. Athens, a city celebrated for its great masters and

Vertex Announces US FDA Approval of ALYFTREK ™ , a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis20.12.2024 21:46:00 CET | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor), a once-daily next-in-class triple combination cystic fibrosis transmembrane conductance regulator (CFTR) modulator for the treatment of cystic fibrosis (CF) in people 6 years and older who have at least one F508del mutation or another mutation in the CFTR gene that is responsive to ALYFTREK. See below for Important Safety Information, including a Boxed Warning. “ALYFTREK is our fifth CFTR modulator to secure FDA approval and represents another significant milestone in our journey to serially innovate and to improve the lives of people living with cystic fibrosis,” said Reshma Kewalramani, M.D., Chief Executive Officer and President of Vertex. “Our north star for more than 20 years has been to address the underlying cause of cystic fibrosis, treat more people with this disease, and bring more people to normal le

Vertex Announces U.S. FDA Approval for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non- F508del TRIKAFTA-Responsive Variants20.12.2024 21:35:00 CET | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 2 and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation that is responsive to TRIKAFTA based on clinical and/or in vitro data. In addition, safety information on liver injury and liver failure has been updated from warnings and precautions to a boxed warning. With this approval, 94 additional non-F508delCFTR mutations have been added to the TRIKAFTA label, and approximately 300 additional people with CF in the U.S. are now eligible for a medicine to treat the underlying cause of their disease for the first time. “Since its first approval in 2019, TRIKAFTA has had a transformative impact on tens of thousands of people living with cystic fibrosis,” sai

HSBC Continental Europe Enters Into a Memorandum of Understanding Regarding Potential Sale of HSBC Assurances Vie (France) to Matmut Société d’Assurance Mutuelle20.12.2024 20:32:00 CET | Press Release

Regulatory News: HSBC Continental Europe has signed a Memorandum of Understanding (‘MOU‘) regarding the potential sale of its French life insurance business, HSBC Assurances Vie (France), to Matmut Société d’Assurance Mutuelle (‘Matmut’) (the “Potential Transaction”). HSBC Assurances Vie (France) provides a wide range of life insurance solutions and services, with over 20 billion euros of outstanding assets, net income1 of 77 million euros and a Solvency II ratio of 287% in 2023. As part of the Potential Transaction, HSBC Continental Europe and Matmut would enter into a long-term arrangement for HSBC Global Asset Management (France) to continue to partner with HSBC Assurances Vie (France). HSBC Assurances Vie (France) will continue its existing distribution arrangements. The Potential Transaction would provide customers and employees of HSBC Insurance Life (France) with the opportunity to join one of the leading French mutual insurance groups, which is in full development, and forms pa

SBC Medical Group Co., Ltd. Sells Two Subsidiaries20.12.2024 13:00:00 CET | Press Release

On December 17, 2024, SBC Medical Group Holdings Incorporated (“SBC Medical”, or the “Company”), announced that its subsidiary, SBC Medical Group Co., Ltd. (hereinafter referred to as "SBCMG"), has decided to sell all shares of its subsidiaries, SBC Kijimadaira Resort Co., Ltd. (hereinafter referred to as "Kijimadaira") and Skynet Academy Co., Ltd. (hereinafter referred to as "SNA"), as outlined below. The decision to sell these subsidiaries was made to concentrate SBCMG's management resources on its core medical services business, in line with its strategy of prioritizing and focusing on key business areas. The subsidiaries being sold operate in the following industries: Kijimadaira: Ski resort operations SNA: Flight training operations The shares will be sold to a company wholly owned by Yoshiyuki Aikawa, the CEO of the Company. Since this transaction constitutes a related party transaction, it was deliberated and approved by the Company’s Board of Directors and Audit Committee. To e

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye